Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard A Fox

Showing results (111-120 of 158) with videos related to

Pageof 16
Sort By:
JCI Insight|July 21, 2017
Multiparametric immune profiling in HPV- oral squamous cell cancerZipei Feng, Daniel Bethmann, Matthias Kappler, et al.
Nature Communications|February 17, 2021
Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cellsRebekka Duhen, Carmen Ballesteros-Merino, Alexandra K Frye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Adjuvant immunization of HLA-A2-positive melanoma patients with a modified gp100 peptide induces peptide-specific CD8+ T-cell responsesJohn W Smith, Edwin B Walker, Bernard A Fox, et al.
Cancer Immunology Research|December 26, 2023
FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor MicroenvironmentDavid A Knorr, Lucas Blanchard, Rom S Leidner, et al.
Journal of Translational Medicine|June 3, 2021
Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd-3rd, 2020, Italy)Paolo A Ascierto, Carlo Bifulco, Fortunato Ciardiello, et al.
Journal for Immunotherapy of Cancer|July 13, 2018
Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)Paolo A Ascierto, James Brugarolas, Luigi Buonaguro, et al.
Journal of Translational Medicine|November 5, 2017
The need for a network to establish and validate predictive biomarkers in cancer immunotherapyGiuseppe V Masucci, Alessandra Cesano, Alexander Eggermont, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 14, 2010
Cancer and inflammation: promise for biologic therapySandra Demaria, Eli Pikarsky, Michael Karin, et al.
Cell|December 10, 2025
Multimodal AI generates virtual population for tumor microenvironment modelingJeya Maria Jose Valanarasu, Hanwen Xu, Naoto Usuyama, et al.
Journal for Immunotherapy of Cancer|January 21, 2016
Novel technologies and emerging biomarkers for personalized cancer immunotherapyJianda Yuan, Priti S Hegde, Raphael Clynes, et al.
Pageof 16

Showing results (111-120 of 158) with videos related to

Sort By:
Pageof 16
JCI Insight|July 21, 2017
Multiparametric immune profiling in HPV- oral squamous cell cancerZipei Feng, Daniel Bethmann, Matthias Kappler, et al.
Nature Communications|February 17, 2021
Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cellsRebekka Duhen, Carmen Ballesteros-Merino, Alexandra K Frye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Adjuvant immunization of HLA-A2-positive melanoma patients with a modified gp100 peptide induces peptide-specific CD8+ T-cell responsesJohn W Smith, Edwin B Walker, Bernard A Fox, et al.
Cancer Immunology Research|December 26, 2023
FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor MicroenvironmentDavid A Knorr, Lucas Blanchard, Rom S Leidner, et al.
Journal of Translational Medicine|June 3, 2021
Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd-3rd, 2020, Italy)Paolo A Ascierto, Carlo Bifulco, Fortunato Ciardiello, et al.
Journal for Immunotherapy of Cancer|July 13, 2018
Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)Paolo A Ascierto, James Brugarolas, Luigi Buonaguro, et al.
Journal of Translational Medicine|November 5, 2017
The need for a network to establish and validate predictive biomarkers in cancer immunotherapyGiuseppe V Masucci, Alessandra Cesano, Alexander Eggermont, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 14, 2010
Cancer and inflammation: promise for biologic therapySandra Demaria, Eli Pikarsky, Michael Karin, et al.
Cell|December 10, 2025
Multimodal AI generates virtual population for tumor microenvironment modelingJeya Maria Jose Valanarasu, Hanwen Xu, Naoto Usuyama, et al.
Journal for Immunotherapy of Cancer|January 21, 2016
Novel technologies and emerging biomarkers for personalized cancer immunotherapyJianda Yuan, Priti S Hegde, Raphael Clynes, et al.
Pageof 16